[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Future Horizons in the UK Immunodiagnostics Market: Supplier Shares and Sales Forecasts

August 2012 | 563 pages | ID: FC0B8793992EN
Venture Planning Group

US$ 4,320.00 US$ 5,400.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Future Horizons in the UK Immunodiagnostics Market: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM, Endocrine, Cancer, Immunoprotein and Abused Drug Tests by Market Segment

This report presents a comprehensive analysis of the UK clinical chemistry and immunodiagnostics markets, including:
  • Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in UK hospitals and commercial laboratories, including controls, calibrators and consumables.
  • Five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
  • Five- and ten-year reagent and instrument sales forecasts.
  • Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-, and low-volume/POC analyzers.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging technologies and their potential market applications.
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.
  • Profiles of 25 current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Market penetration strategies, entry barriers and risks.
Contains 563 pages and 103 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. MAJOR ROUTINE CHEMISTRY TESTS


1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin, Total 8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cardio CRP
12. Cholesterol
13. Cholinesterase
14. CRP
15. Creatinine
16. Electrolytes
  a. Carbon Dioxide/Bicarbonate
  b. Chloride
  c. Potassium
  d. Sodium
17. Ferritin
18. Fructosamine
19. Gamma-Glutamyl Transpeptidase (GGT)
20. Glucose
21. High Density Lipoprotein (HDL)
22. Homocysteine
23. Iron
24. Lactate Dehydrogenase (LDH)
25. Magnesium
26. Phosphorus
27. Protein
28. Triglycerides
29. Uric Acid
30. Troponin

B. THERAPEUTIC DRUG MONITORING (TDM)

1. Overview
2. Carbamazepine
3. Cyclosporin
4. Digoxin
5. Everolimus
6. Gentamicin
7. Lamotrigine/Lamictal
8. Levetiracetam
9. Lidocaine
10. Lithium
11. NAPA/Procainamide
12. Phenytoin
13. Quinidine
14. Sirolimus
15. Tacrolimus
16. Theophylline
17. Topirimate
18. Valproic Acid

C. ENDOCRINE FUNCTION TESTS

1. Cortisol
2. Follicle-Stimulating Hormone (FSH)
3. Gastrin
4. Growth Hormone/IGF-1
5. Human Chorionic Gonadotropin (HCG)
6. LH
7. PTH/IO PTH
8. Prolactin
9. T3
10. T3 Free
11. T3 Uptake
12. T4 (Thyroxine)
13. T4 Free
14. TBG
15. Thyroglobulin Ab
16. TPO Ab
17. TSH

D. TUMOR MARKERS AND SPECIAL CHEMISTRY TESTS

1. AFP
2. CA 15-3
3. CA 19-9
4. CA 27-29
5. Carcinoembrionic Antigen (CEA)
6. Folate/Folic Acid
7. HCG
8. 25-Hydroxy Vitamin D2 and D3
9. Occult Blood
10. Prostate-Specific Antigen (PSA)
11. Thyroglobulin
12. Vitamin B-12

E. IMMUNOPROTEIN TESTS

1. Complement
  a. C3
  b. C4
2. Free Light Chains
3. Immunofixation
4. Immunoglobulins (IgA, IgE, IgG, IgM)
5. Haptoglobin
6. Prealbumin
7. Protein Electrophoresis

F. DRUGS OF ABUSE

1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants

G. INSTRUMENTATION REVIEW
: Operating Characteristics and Features of High-, Medium-, and Low-Volume/POC
Analyzers Manufactured By:
    Abaxis
    Abbott
    Alere/Inverness
    Alfa Wassermann
    AMS
    Awareness Technologies
    Beckman Coulter/Olympus
    Binding Site
    bioMerieux
    Carolina Chemistries
    DiaSorin
    Grifols
    Horiba
    Medica
    Nova Biomedical
    Ortho-Clinical Diagnostics
    Polymedco
    Randox
    Roche
    Siemens
    Tosoh
    Vital Diagnostics

H. MAJOR IN VITRO DIAGNOSTIC TECHNOLOGIES AND THEIR POTENTIAL APPLICATIONS

1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
  a. Technological Principle
  d. Chemiluminescence
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical
  d. Radioimmunoassays (RIA)
  e. Immunoprecipitation
  f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

U.K.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
TESTING MARKETS

  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

    Abbott Laboratories
    AdnaGen
    Beckman Coulter/Danaher
    Biomedical Diagnostics
    BioMerieux
    Bio-Rad
    Dako
    DiaSorin
    Eiken
    Fujirebio
    Instrumentation Laboratory
    Kyowa Medex
    Matritech
    Ortho-Clinical Diagnostics
    Roche
    Siemens
    Sysmex
    Thermo Fisher
    Tosoh
    Wako
    Wallac/PE

LIST OF TABLES

Major Companies Developing or Marketing Albumin Tests
Major Companies Developing or Marketing Alkaline Phosphatase Tests
Major Companies Developing or Marketing ALT/SGPT Tests
Major Companies Developing or Marketing Amylase Tests
Major Companies Developing or Marketing AST/SGOT Tests
Major Companies Developing or Marketing Bilirubin Tests
Major Companies Developing or Marketing Blood Gas Analyzers
Major Companies Developing or Marketing BUN Tests
Major Companies Developing or Marketing Calcium Tests
Major Companies Developing or Marketing Cholesterol Tests
Major Companies Developing or Marketing Creatinine Tests
Major Companies Developing or Marketing Electrolyte Tests
Major Companies Developing or Marketing GGT Tests
Major Companies Developing or Marketing Glucose Tests
Major Companies Developing or Marketing HDL Tests
Major Companies Developing or Marketing Iron Tests
Major Companies Developing or Marketing LDH Tests
Major Companies Developing or Marketing Magnesium Tests
Major Companies Developing or Marketing Phosphorus Tests
Major Companies Developing or Marketing Protein Tests
Major Companies Developing or Marketing Triglycerides Tests
Major Companies Developing or Marketing Uric Acid Tests
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin/Dilantin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Acid Tests
Major Companies Developing or Marketing FSH Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing LH Tests
Major Companies Developing or Marketing Prolactin Tests
Major Companies Developing or Marketing T3 Tests
Major Companies Developing or Marketing T4 Tests
Major Companies Developing or Marketing TSH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Vitamin B-12/Folate Tests
Major Companies Developing or Marketing CRP Tests
Major Companies Developing or Marketing Drugs of Abuse Tests
Major Companies Developing or Marketing Biosensors for Clinical Chemistry Testing
Executive Summary Table: U.K., Clinical Chemistry and Immunoassay Test Volume And Diagnostics Sales Forecast By Test Category
U.K., Laboratories Performing Chemistry and Immunoassay Testing By Market Segment
U.K., Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
U.K., Commercial/Private Laboratories Performing Chemistry and Immunoassay Tests By Annual Test Volume
U.K., Total Chemistry and Immunoassay Specimen Volume Forecast
U.K., All Market Segments, Specimen Volume Forecast By Test Category
U.K., Total Clinical Chemistry and Immunoassay Test Volume Forecast By Test Category
U.K., Routine Chemistry Test Volume Forecast By Market Segment
U.K., Endocrine Function Test Volume Forecast By Market Segment
U.K., Tumor Markers and Special Chemistry Test Volume Forecast By Market Segment
U.K., Immunoprotein Test Volume Forecast By Market Segment
U.K., TDM Test Volume Forecast By Market Segment
U.K., Drugs of Abuse Test Volume Forecast By Market Segment
U.K., All Market Segments, Profiles, Panels and Individual Tests Forecast
U.K., Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
U.K., Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
U.K., All Market Segments, Routine Chemistry Test Volume Forecast by Assay
U.K., Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by Assay
U.K., All Market Segments, Endocrine Function Test Volume Forecast by Assay
U.K., Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Endocrine Function Test Volume Forecast by Assay
U.K., All Market Segments, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
U.K., All Market Segments, Immunoprotein Test Volume Forecast by Assay
U.K., Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Immunoprotein Test Volume Forecast by Assay
U.K., All Market Segments, TDM Test Volume Forecast by Assay by Assay
U.K., Hospital Laboratories, TDM Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
U.K., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Total Clinical Chemistry and Immunoassay Reagent Market Forecast By Test Category
U.K., Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
U.K., Routine Chemistry Reagent Market Forecast By Market Segment
U.K., Endocrine Function Reagent Market Forecast By Market Segment
U.K., Tumor Markers and Special Chemistry Reagent Market Forecast By Market Segment
U.K., Immunoprotein Reagent Market Forecast By Market Segment
U.K., TDM Reagent Market Forecast By Market Segment
U.K., Drugs of Abuse Reagent Market Forecast By Market Segment
U.K., All Market Segments, Routine Chemistry Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Routine Chemistry Reagent Market Forecast by Assay
U.K., All Market Segments, Endocrine Function Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Endocrine Function Reagent Market Forecast by Assay
U.K., All Market Segments, Immunoprotein Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Immunoprotein Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Immunoprotein Reagent Market Forecast by Assay
U.K., All Market Segments, TDM Reagent Market Forecast by Assay
U.K., Hospital Laboratories, TDM Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.K., All Market Segments, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
U.K., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
U.K., Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
U.K., Major Suppliers of Immunoassay Diagnostic Products, Estimated Sales and Market Shares


More Publications